Trial intelligence / Profile preview

HFA vs CFC beclomethasone + salbutamol fixed-combination trial in uncontrolled adult asthma

2007-002816-25Phase 3Completed

Sponsor
Chiesi Farmaceutici S.p.A.
Start
Jul 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of beclomethasone dipropionate and salbutamol in asthma (2 arms), sponsored by Chiesi Farmaceutici S.p.A. Primary endpoint: Mean morning peak expiratory flow. Started Jul 2007; status: completed.

02

Drugs

beclomethasone dipropionatesalbutamol
03

Conditions

asthma

Beyond the preview

Go deeper on 2007-002816-25.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-002816-25.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call